MicroRNA-122

A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity

Richard Kia, Lorna Kelly, Rowena L C Sison-Young, Fang Zhang, Chris S. Pridgeon, James A. Heslop, Pete Metcalfe, Neil R. Kitteringham, Melissa Baxter, Sean Harrison, Neil A. Hanley, Zoë D. Burke, Michael P. Storm, Melanie J. Welham, David Tosh, Barbara Küppers-Munther, Josefina Edsbagge, Philip J. Starkey Lewis, Frank Bonner, Ernie Harpur & 6 others James Sidaway, Joanne Bowes, Stephen W. Fenwick, Hassan Malik, Chris E P Goldring, B. Kevin Park

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the niche environment in the human liver. However, a specific marker of hepatocyte perturbation, required to discriminate hepatocyte damage from non-specific cellular toxicity contributed by non-hepatocyte cell types or immature differentiated cells is currently lacking, as the cytotoxicity assays routinely used in in vitro toxicology research depend on intracellular molecules which are ubiquitously present in all eukaryotic cell types. In this study, we demonstrate that microRNA-122 (miR-122) detection in cell culture media can be used as a hepatocyte-enriched in vitro marker of druginduced toxicity in homogeneous cultures of hepatic cells, and a cell-specific marker of toxicity of hepatic cells in heterogeneous cultures such as HLCs generated from various differentiation protocols and pluripotent stem cell lines, where conventional cytotoxicity assays using generic cellular markers may not be appropriate. We show that the sensitivity of the miR-122 cytotoxicity assay is similar to conventional assays that measure lactate dehydrogenase activity and intracellular adenosine triphosphate when applied in hepatic models with high levels of intracellular miR-122, and can be multiplexed with other assays. MiR-122 as a biomarker also has the potential to bridge results in in vitro experiments to in vivo animal models and human samples using the same assay, and to link findings from clinical studies in determining the relevance of in vitro models being developed for the study of drug-induced liver injury.

Original languageEnglish
Pages (from-to)173-185
Number of pages13
JournalToxicological Sciences
Volume144
Issue number1
Early online date18 Dec 2014
DOIs
Publication statusPublished - Mar 2015

Fingerprint

MicroRNAs
Toxicity
Hepatocytes
Assays
Pharmaceutical Preparations
Cytotoxicity
Pluripotent Stem Cells
Stem cells
Liver
Chemical and Drug Induced Liver Injury
In Vitro Techniques
Eukaryotic Cells
Biomarkers
Coculture Techniques
Drug-Related Side Effects and Adverse Reactions
L-Lactate Dehydrogenase
Cell culture
Toxicology
Culture Media
Animals

Keywords

  • Bridging biomarker
  • Cell-specific biomarker
  • Cytotoxicity
  • Drug-induced liver injury
  • Hepatocytes
  • In vitro model
  • microRNA

Cite this

Kia, R., Kelly, L., Sison-Young, R. L. C., Zhang, F., Pridgeon, C. S., Heslop, J. A., ... Kevin Park, B. (2015). MicroRNA-122: A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity. Toxicological Sciences, 144(1), 173-185. https://doi.org/10.1093/toxsci/kfu269

MicroRNA-122 : A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity. / Kia, Richard; Kelly, Lorna; Sison-Young, Rowena L C; Zhang, Fang; Pridgeon, Chris S.; Heslop, James A.; Metcalfe, Pete; Kitteringham, Neil R.; Baxter, Melissa; Harrison, Sean; Hanley, Neil A.; Burke, Zoë D.; Storm, Michael P.; Welham, Melanie J.; Tosh, David; Küppers-Munther, Barbara; Edsbagge, Josefina; Starkey Lewis, Philip J.; Bonner, Frank; Harpur, Ernie; Sidaway, James; Bowes, Joanne; Fenwick, Stephen W.; Malik, Hassan; Goldring, Chris E P; Kevin Park, B.

In: Toxicological Sciences, Vol. 144, No. 1, 03.2015, p. 173-185.

Research output: Contribution to journalArticle

Kia, R, Kelly, L, Sison-Young, RLC, Zhang, F, Pridgeon, CS, Heslop, JA, Metcalfe, P, Kitteringham, NR, Baxter, M, Harrison, S, Hanley, NA, Burke, ZD, Storm, MP, Welham, MJ, Tosh, D, Küppers-Munther, B, Edsbagge, J, Starkey Lewis, PJ, Bonner, F, Harpur, E, Sidaway, J, Bowes, J, Fenwick, SW, Malik, H, Goldring, CEP & Kevin Park, B 2015, 'MicroRNA-122: A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity', Toxicological Sciences, vol. 144, no. 1, pp. 173-185. https://doi.org/10.1093/toxsci/kfu269
Kia R, Kelly L, Sison-Young RLC, Zhang F, Pridgeon CS, Heslop JA et al. MicroRNA-122: A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity. Toxicological Sciences. 2015 Mar;144(1):173-185. https://doi.org/10.1093/toxsci/kfu269
Kia, Richard ; Kelly, Lorna ; Sison-Young, Rowena L C ; Zhang, Fang ; Pridgeon, Chris S. ; Heslop, James A. ; Metcalfe, Pete ; Kitteringham, Neil R. ; Baxter, Melissa ; Harrison, Sean ; Hanley, Neil A. ; Burke, Zoë D. ; Storm, Michael P. ; Welham, Melanie J. ; Tosh, David ; Küppers-Munther, Barbara ; Edsbagge, Josefina ; Starkey Lewis, Philip J. ; Bonner, Frank ; Harpur, Ernie ; Sidaway, James ; Bowes, Joanne ; Fenwick, Stephen W. ; Malik, Hassan ; Goldring, Chris E P ; Kevin Park, B. / MicroRNA-122 : A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity. In: Toxicological Sciences. 2015 ; Vol. 144, No. 1. pp. 173-185.
@article{7d3f596a8c45489db3e622c07d36ce0c,
title = "MicroRNA-122: A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity",
abstract = "Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the niche environment in the human liver. However, a specific marker of hepatocyte perturbation, required to discriminate hepatocyte damage from non-specific cellular toxicity contributed by non-hepatocyte cell types or immature differentiated cells is currently lacking, as the cytotoxicity assays routinely used in in vitro toxicology research depend on intracellular molecules which are ubiquitously present in all eukaryotic cell types. In this study, we demonstrate that microRNA-122 (miR-122) detection in cell culture media can be used as a hepatocyte-enriched in vitro marker of druginduced toxicity in homogeneous cultures of hepatic cells, and a cell-specific marker of toxicity of hepatic cells in heterogeneous cultures such as HLCs generated from various differentiation protocols and pluripotent stem cell lines, where conventional cytotoxicity assays using generic cellular markers may not be appropriate. We show that the sensitivity of the miR-122 cytotoxicity assay is similar to conventional assays that measure lactate dehydrogenase activity and intracellular adenosine triphosphate when applied in hepatic models with high levels of intracellular miR-122, and can be multiplexed with other assays. MiR-122 as a biomarker also has the potential to bridge results in in vitro experiments to in vivo animal models and human samples using the same assay, and to link findings from clinical studies in determining the relevance of in vitro models being developed for the study of drug-induced liver injury.",
keywords = "Bridging biomarker, Cell-specific biomarker, Cytotoxicity, Drug-induced liver injury, Hepatocytes, In vitro model, microRNA",
author = "Richard Kia and Lorna Kelly and Sison-Young, {Rowena L C} and Fang Zhang and Pridgeon, {Chris S.} and Heslop, {James A.} and Pete Metcalfe and Kitteringham, {Neil R.} and Melissa Baxter and Sean Harrison and Hanley, {Neil A.} and Burke, {Zo{\"e} D.} and Storm, {Michael P.} and Welham, {Melanie J.} and David Tosh and Barbara K{\"u}ppers-Munther and Josefina Edsbagge and {Starkey Lewis}, {Philip J.} and Frank Bonner and Ernie Harpur and James Sidaway and Joanne Bowes and Fenwick, {Stephen W.} and Hassan Malik and Goldring, {Chris E P} and {Kevin Park}, B.",
year = "2015",
month = "3",
doi = "10.1093/toxsci/kfu269",
language = "English",
volume = "144",
pages = "173--185",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - MicroRNA-122

T2 - A novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity

AU - Kia, Richard

AU - Kelly, Lorna

AU - Sison-Young, Rowena L C

AU - Zhang, Fang

AU - Pridgeon, Chris S.

AU - Heslop, James A.

AU - Metcalfe, Pete

AU - Kitteringham, Neil R.

AU - Baxter, Melissa

AU - Harrison, Sean

AU - Hanley, Neil A.

AU - Burke, Zoë D.

AU - Storm, Michael P.

AU - Welham, Melanie J.

AU - Tosh, David

AU - Küppers-Munther, Barbara

AU - Edsbagge, Josefina

AU - Starkey Lewis, Philip J.

AU - Bonner, Frank

AU - Harpur, Ernie

AU - Sidaway, James

AU - Bowes, Joanne

AU - Fenwick, Stephen W.

AU - Malik, Hassan

AU - Goldring, Chris E P

AU - Kevin Park, B.

PY - 2015/3

Y1 - 2015/3

N2 - Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the niche environment in the human liver. However, a specific marker of hepatocyte perturbation, required to discriminate hepatocyte damage from non-specific cellular toxicity contributed by non-hepatocyte cell types or immature differentiated cells is currently lacking, as the cytotoxicity assays routinely used in in vitro toxicology research depend on intracellular molecules which are ubiquitously present in all eukaryotic cell types. In this study, we demonstrate that microRNA-122 (miR-122) detection in cell culture media can be used as a hepatocyte-enriched in vitro marker of druginduced toxicity in homogeneous cultures of hepatic cells, and a cell-specific marker of toxicity of hepatic cells in heterogeneous cultures such as HLCs generated from various differentiation protocols and pluripotent stem cell lines, where conventional cytotoxicity assays using generic cellular markers may not be appropriate. We show that the sensitivity of the miR-122 cytotoxicity assay is similar to conventional assays that measure lactate dehydrogenase activity and intracellular adenosine triphosphate when applied in hepatic models with high levels of intracellular miR-122, and can be multiplexed with other assays. MiR-122 as a biomarker also has the potential to bridge results in in vitro experiments to in vivo animal models and human samples using the same assay, and to link findings from clinical studies in determining the relevance of in vitro models being developed for the study of drug-induced liver injury.

AB - Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the niche environment in the human liver. However, a specific marker of hepatocyte perturbation, required to discriminate hepatocyte damage from non-specific cellular toxicity contributed by non-hepatocyte cell types or immature differentiated cells is currently lacking, as the cytotoxicity assays routinely used in in vitro toxicology research depend on intracellular molecules which are ubiquitously present in all eukaryotic cell types. In this study, we demonstrate that microRNA-122 (miR-122) detection in cell culture media can be used as a hepatocyte-enriched in vitro marker of druginduced toxicity in homogeneous cultures of hepatic cells, and a cell-specific marker of toxicity of hepatic cells in heterogeneous cultures such as HLCs generated from various differentiation protocols and pluripotent stem cell lines, where conventional cytotoxicity assays using generic cellular markers may not be appropriate. We show that the sensitivity of the miR-122 cytotoxicity assay is similar to conventional assays that measure lactate dehydrogenase activity and intracellular adenosine triphosphate when applied in hepatic models with high levels of intracellular miR-122, and can be multiplexed with other assays. MiR-122 as a biomarker also has the potential to bridge results in in vitro experiments to in vivo animal models and human samples using the same assay, and to link findings from clinical studies in determining the relevance of in vitro models being developed for the study of drug-induced liver injury.

KW - Bridging biomarker

KW - Cell-specific biomarker

KW - Cytotoxicity

KW - Drug-induced liver injury

KW - Hepatocytes

KW - In vitro model

KW - microRNA

UR - http://www.scopus.com/inward/record.url?scp=84924455476&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1093/toxsci/kfu269

U2 - 10.1093/toxsci/kfu269

DO - 10.1093/toxsci/kfu269

M3 - Article

VL - 144

SP - 173

EP - 185

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -